Surely, everyone can benefit in some way from yoga. Women with breast cancer that has spread beyond the breast, however, may benefit greatly from a tailored program featuring gentle yoga postures, breathing exercises, and meditation.

The great benefits: less pain and fatigue and more vigor, relaxation, and acceptance," says Dr. James W. Carson from Duke University Medical Center and lead of a study published in the Journal of Pain and Symptom Management.

Carson says women with advanced breast cancer need effective methods for curbing cancer-related symptoms.

The pilot study included 13 women who attended yoga classes once per week for eight weeks. The women, with an average age of 59 and with diagnoses occurring an average of seven years earlier, were helped significantly. They felt more invigorated and gained a greater sense of acceptance. They also found they felt better not only on the day they practiced yoga but the next day too.

This study offers the first, small-scale evidence for yoga's potential benefits for women with limited life expectancy.

Cancer cases are expected to more than double between the years 2000 and 2030, says the director of the World Health Organization's International Agency for Research on Cancer.

This upward climb will occur primarily in poor countries due to an increase in population growth, longer life expectancy, more smoking, and a lack of health care in low and medium-resource countries.

"What's going to happen between now and 2030 is that the population is going to increase from about 6.5 billion to 8 billion in 2030," Dr. Peter Boyle reports. "So even if the risks remain constant at each five-year age group, because we've got more people around, we're going to have more cases of cancer.

It's the unfortunate successes for developed countries over the past 40 years, such as the export of cigarette smoking and alcohol consumption, that have doomed poorer countries, says Boyle.

Consider this definition of doom: By the year 2030, there will be 27 million cases of cancer, 17 million deaths caused by the disease, and 75 million people living with cancer.

If clinical trials go well, a new drug simulating the effects of normal sunlight and increasing the life expectancy of prostate cancer patients, could be available in 2009.

The drug, Asentar, provided levels of vitamin D between 50 and 100 times higher than levels delivered by the sun and could double life expectancy from nine to 18 months for those taking the pills. Absent would be any of the consequences associated with such an overdose.

"An extension of nine months would be very significant in my view," said Nick James of the University of Birmingham. "If the results of the phase III trial are as good as those of the phase II trial, that would be significant."

Details about this study can be found in the journal Chemistry & Industry.

I feel fortunate to have received every cancer drug I needed to fight my breast cancer -- Adriamycin, Cytoxan, Herceptin, and every nausea pill, pain capsule, and anti-anxiety formula on the market. I got exactly what doctors thought I needed -- without worry about availability or funding or politics. I am lucky. Some in the UK are not so lucky.

Two targeted therapies for bowel cancer will not be used in Britain's state-run health system, according to NICE -- the National Institute for Health and Clinical Excellence. NICE, the country's financial watchdog, determined the high cost of the medicines meant their use was not compatible with the best use of resources. Patients are angry because these same two drugs -- Avastin and Erbitux -- are used widely in the United States and in much of Europe. And while neither drug offers a cure for bowel cancer, both treatments have been shown in clinical trials to extend life expectancy by four or five months in some patients.

Based on doses given during the trials, it is estimated that the average cost of treating one patient with Avastin would be around 16,800 pounds and with Erbitux -- about 11,700 pounds. Apparently, this is too much. But according to Hilary Whittaker of the charity Beating Bowel Cancer, the decision to deprive patients of this medication is a scandal. I agree. And for these patients, I am sad.

Recently, International Agency for Research on Cancer researchers concluded a study which stated that 3.6 percent of all cancer cases worldwide are related to alcohol drinking. Today, the Centre of Public Health at Liverpool John Moores University published a report that alcoholism and binge drinking in the northern Britain cities of Newcastle-upon-Tyne, Liverpool and Durham will shorten the lives of men and women who live there and create years of health-related illnesses.

The blame for the drinking problems focuses on the government's allowance of 24-hour drinking, inexpensive booze, a night-time economy of bars and clubs and a failure to educate the public on the dangers of excessive drinking, binge drinking and alcoholism. This report, along with political conservatives, are making a public statement against what they call irresponsible actions on the part of the British government that would create an environment that promotes excess drinking, binge drinking and alcoholism.

The report indicated almost three in ten people admit binge drinking. According to director of the Centre for Public Health Professor Mark Bellis, "We hope that making these statistics widely available will highlight that we are no longer a nation enjoying a harmless tipple but increasingly one developing a dangerous alcohol addiction."